EP1349961A4 - Verfahren zur bestimmung der biologischen effekte von verbindungen auf die genexpression - Google Patents

Verfahren zur bestimmung der biologischen effekte von verbindungen auf die genexpression

Info

Publication number
EP1349961A4
EP1349961A4 EP01992034A EP01992034A EP1349961A4 EP 1349961 A4 EP1349961 A4 EP 1349961A4 EP 01992034 A EP01992034 A EP 01992034A EP 01992034 A EP01992034 A EP 01992034A EP 1349961 A4 EP1349961 A4 EP 1349961A4
Authority
EP
European Patent Office
Prior art keywords
compounds
determining
methods
gene expression
biological effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01992034A
Other languages
English (en)
French (fr)
Other versions
EP1349961A2 (de
Inventor
Christopher C Adams
Paul Labhart
Mary E Harper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genpathway Inc
Original Assignee
Cistem Molecular Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cistem Molecular Corp filed Critical Cistem Molecular Corp
Publication of EP1349961A2 publication Critical patent/EP1349961A2/de
Publication of EP1349961A4 publication Critical patent/EP1349961A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP01992034A 2000-11-13 2001-11-09 Verfahren zur bestimmung der biologischen effekte von verbindungen auf die genexpression Withdrawn EP1349961A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24833900P 2000-11-13 2000-11-13
US248339P 2000-11-13
PCT/US2001/046927 WO2002038734A2 (en) 2000-11-13 2001-11-09 Methods for determining the biological effects of compounds on gene expression

Publications (2)

Publication Number Publication Date
EP1349961A2 EP1349961A2 (de) 2003-10-08
EP1349961A4 true EP1349961A4 (de) 2005-01-26

Family

ID=22938682

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01992034A Withdrawn EP1349961A4 (de) 2000-11-13 2001-11-09 Verfahren zur bestimmung der biologischen effekte von verbindungen auf die genexpression

Country Status (4)

Country Link
EP (1) EP1349961A4 (de)
AU (1) AU2002232510A1 (de)
CA (1) CA2431047A1 (de)
WO (1) WO2002038734A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040058356A1 (en) * 2001-03-01 2004-03-25 Warren Mary E. Methods for global profiling gene regulatory element activity
US7981842B2 (en) 2001-06-08 2011-07-19 Panomics, Inc. Method for detecting transcription factor-protein interactions
WO2002101351A2 (en) * 2001-06-08 2002-12-19 Panomics, Inc. Method for detecting transcription factor-protein interactions
CA3094974A1 (en) * 2018-03-23 2019-09-26 Whitehead Institute For Biomedical Research Methods and assays for modulating gene transcription by modulating condensates
CN108548780A (zh) * 2018-03-30 2018-09-18 中国人民解放军第二军医大学 转录因子芯片试剂盒及高通量筛选靶基因转录因子的方法
CN113424064A (zh) 2019-02-08 2021-09-21 露点治疗公司 表征化合物的凝聚物缔合特征的方法及其用途
WO2020232416A1 (en) * 2019-05-15 2020-11-19 Whitehead Institute For Biomedical Research Methods of characterizing and utilizing agent-condensate interactions
KR20220084047A (ko) 2019-09-18 2022-06-21 듀포인트 테라퓨틱스, 인크. 응축물 관련 특이성에 대한 스크리닝 방법 및 이의 용도
WO2022171163A1 (en) * 2021-02-10 2022-08-18 Etern Biopharma (Shanghai) Co., Ltd. Methods of modulating androgen receptor condensates

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620439A2 (de) * 1993-04-16 1994-10-19 Roche Diagnostics GmbH Verfahren zur Bestimmung der Bindung von Transkriptionsfaktoren an Nukleinsäuren
US5821053A (en) * 1995-02-10 1998-10-13 Center For Blood Research, Inc. LIL-Stat DNA binding sites and methods for identifying inhibitory binding agents
WO1999019510A1 (en) * 1997-10-10 1999-04-22 President And Fellows Of Harvard College Surface-bound, double-stranded dna protein arrays
US6066452A (en) * 1997-08-06 2000-05-23 Yale University Multiplex selection technique for identifying protein-binding sites and DNA-binding proteins
US6100035A (en) * 1998-07-14 2000-08-08 Cistem Molecular Corporation Method of identifying cis acting nucleic acid elements
EP1136567A1 (de) * 2000-03-24 2001-09-26 Advanced Array Technologies S.A. Methode und Kit zum Auffinden, Nachweis und/oder Quantifizieren von Transkriptionsfaktoren

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5986055A (en) * 1997-11-13 1999-11-16 Curagen Corporation CDK2 interactions

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620439A2 (de) * 1993-04-16 1994-10-19 Roche Diagnostics GmbH Verfahren zur Bestimmung der Bindung von Transkriptionsfaktoren an Nukleinsäuren
US5821053A (en) * 1995-02-10 1998-10-13 Center For Blood Research, Inc. LIL-Stat DNA binding sites and methods for identifying inhibitory binding agents
US6066452A (en) * 1997-08-06 2000-05-23 Yale University Multiplex selection technique for identifying protein-binding sites and DNA-binding proteins
WO1999019510A1 (en) * 1997-10-10 1999-04-22 President And Fellows Of Harvard College Surface-bound, double-stranded dna protein arrays
US6100035A (en) * 1998-07-14 2000-08-08 Cistem Molecular Corporation Method of identifying cis acting nucleic acid elements
EP1136567A1 (de) * 2000-03-24 2001-09-26 Advanced Array Technologies S.A. Methode und Kit zum Auffinden, Nachweis und/oder Quantifizieren von Transkriptionsfaktoren

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BULYK M L ET AL: "Quantifying DNA-protein interactions by double-stranded DNA arrays", NATURE BIOTECHNOLOGY, NATURE PUBLISHING, US, vol. 17, June 1999 (1999-06-01), pages 573 - 577, XP002168458, ISSN: 1087-0156 *
BULYK MARTHA L ET AL: "Exploring the DNA-binding specificities of zinc fingers with DNA microarrays", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 98, no. 13, 19 June 2001 (2001-06-19), pages 7158 - 7163, XP002174591, ISSN: 0027-8424 *
DUCY P ET AL: "TWO DISTINCT OSTEOBLAST-SPECIFIC CIS-ACTING ELEMENTS CONTROL EXPRESSION OF A MOUSE OSTEOCALCIN GENE", MOLECULAR AND CELLULAR BIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, vol. 15, no. 4, April 1995 (1995-04-01), pages 1858 - 1869, XP001152915, ISSN: 0270-7306 *
See also references of WO0238734A3 *

Also Published As

Publication number Publication date
WO2002038734A2 (en) 2002-05-16
EP1349961A2 (de) 2003-10-08
AU2002232510A1 (en) 2002-05-21
CA2431047A1 (en) 2002-05-16
WO2002038734A3 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
AU2001234608A1 (en) Methods for analysis of gene expression
DE60140000D1 (en) Biosensor
DE60137111D1 (en) Biosensor
DE60115288D1 (en) Biosensor
EP1197749A4 (de) Biosensor
EP1314978A4 (de) Biosensor
EP1296141A4 (de) Biozensor
IL151865A0 (en) Compositions and methods for detecting and quantifying gene expression
DE60121404D1 (en) Biosensor
IL190391A0 (en) Genes for the biosynthesis of epothilones
HK1077332A1 (en) A method for determining the biological activity of defibrotide
AU2001241733A1 (en) Methods for determining single nucleotide variations
AU2002312859A1 (en) Method for determining gene expression
HK1038796A1 (en) Method of earth-resistance measurement.
EP1287404A4 (de) Verfahren zur immobilisierung von oligonukleotiden, welches das cycloaddition-bikonjugierungs-verfahren anwendet
AU1183902A (en) Methods for parallel measurement of genetic variations
EP1349961A4 (de) Verfahren zur bestimmung der biologischen effekte von verbindungen auf die genexpression
AU9396401A (en) Method of assaying pyrrole-containing biological compounds
AU2002246676A1 (en) Methods for determining organisms
AU2001265759A1 (en) Method for the highly parallel analysis of polymorphisms
AU2002361399A8 (en) Method for the quantitative determination of gene expression
AU2002360560A8 (en) Method for the analysis of differential gene expression
AU2001296261A1 (en) Haplotypes of the gpr7 gene
AU2001251243A1 (en) Haplotypes of the chrnb2 gene
AU2001279557A1 (en) High-throughput method for examining the effects of membrane-impermeable compounds that contain no gene

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030611

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20041209

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12Q 1/68 A

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GENPATHWAY, INC.

17Q First examination report despatched

Effective date: 20050412

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051025